NCT07459907 Gestational Diabetes and Health Outcomes in Mothers and Babies
| NCT ID | NCT07459907 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Graz |
| Condition | Gestational Diabetes Mellitus (GDM) |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2025-06-15 |
| Primary Completion | 2030-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2025-06-15 with a primary completion date of 2030-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Gestational diabetes mellitus (GDM) is a common pregnancy complication characterized by impaired glucose metabolism and increased insulin resistance. GDM is associated with adverse pregnancy outcomes and an increased long-term risk of metabolic and cardiovascular disease for both mother and offspring. This prospective observational cohort study aims to establish a longitudinal pregnancy and birth cohort of women diagnosed with GDM. Pregnant women with a positive 75 g oral glucose tolerance test (OGTT) between gestational weeks 24 and 28 will be recruited after diagnosis and followed through late pregnancy, delivery, and early postpartum. Participants will undergo two study visits during pregnancy, sample collection at delivery, and one postpartum visit 8-12 weeks after birth. Clinical data, physical measurements, questionnaire-based information, and biological samples will be collected from mothers and infants to enable comprehensive phenotyping of GDM pregnancies. Data and biosamples from this cohort will be used for descriptive and hypothesis-driven analyses and may be compared with data from an existing longitudinal cohort of healthy pregnancies to support interpretation of GDM-related changes.
Eligibility Criteria
Inclusion Criteria: * ongoing pregnancy prior to the 32nd gestational week and a positive GDM screening Exclusion Criteria: * gestational age 32nd gestational week * fetal genetic anomalies /malformation
Contact & Investigator
Christina Stern, Dr. med.
PRINCIPAL INVESTIGATOR
Medical University of Graz
Frequently Asked Questions
Who can join the NCT07459907 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Gestational Diabetes Mellitus (GDM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07459907 currently recruiting?
Yes, NCT07459907 is actively recruiting participants. Contact the research team at evelyn.jantscher-krenn@medunigraz.at for enrollment information.
Where is the NCT07459907 trial being conducted?
This trial is being conducted at Graz, Austria.
Who is sponsoring the NCT07459907 clinical trial?
NCT07459907 is sponsored by Medical University of Graz. The principal investigator is Christina Stern, Dr. med. at Medical University of Graz. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.